146 related articles for article (PubMed ID: 12196762)
1. Photoeruption in a patient treated with capecitabine (Xeloda) for metastatic breast cancer.
Willey A; Glusac EJ; Bolognia JL
J Am Acad Dermatol; 2002 Sep; 47(3):453. PubMed ID: 12196762
[No Abstract] [Full Text] [Related]
2. Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer.
Hague JS; Ilchyshyn A
Clin Exp Dermatol; 2007 Jan; 32(1):102-3. PubMed ID: 16879449
[No Abstract] [Full Text] [Related]
3. Onychomadesis and onycholysis associated with capecitabine.
Chen GY; Chen YH; Hsu MM; Tsao CJ; Chen WC
Br J Dermatol; 2001 Sep; 145(3):521-2. PubMed ID: 11531857
[No Abstract] [Full Text] [Related]
4. Effect of capecitabine on mean corpuscular volume in patients with metastatic breast cancer.
Karvellas CJ; Sawyer M; Hamilton M; Mackey JR
Am J Clin Oncol; 2004 Aug; 27(4):364-8. PubMed ID: 15289729
[TBL] [Abstract][Full Text] [Related]
5. Photosensitive lichenoid drug eruption to capecitabine.
Walker G; Lane N; Parekh P
J Am Acad Dermatol; 2014 Aug; 71(2):e52-3. PubMed ID: 25037814
[No Abstract] [Full Text] [Related]
6. Capecitabine induces severe angina-like chest pain.
Kuppens IE; Boot H; Beijnen JH; Schellens JH; Labadie J
Ann Intern Med; 2004 Mar; 140(6):494-5. PubMed ID: 15023730
[No Abstract] [Full Text] [Related]
7. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
Dalmau J; Roé E; Puig L; Alomar A
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
[No Abstract] [Full Text] [Related]
8. Significant association between hand-foot syndrome and efficacy of capecitabine in patients with metastatic breast cancer.
Azuma Y; Hata K; Sai K; Udagawa R; Hirakawa A; Tohkin M; Ryushima Y; Makino Y; Yokote N; Morikawa N; Fujiwara Y; Saito Y; Yamamoto H
Biol Pharm Bull; 2012; 35(5):717-24. PubMed ID: 22687407
[TBL] [Abstract][Full Text] [Related]
9. Mucositis as a treatment-limiting side effect in the use of capecitabine for the treatment of metastatic breast cancer.
Bell KA; Perna AG; Hsu S
J Am Acad Dermatol; 2001 Nov; 45(5):790-1. PubMed ID: 11606938
[No Abstract] [Full Text] [Related]
10. Dear doctor: we really are not sure what dose of capecitabine you should prescribe for your patient.
Ratain MJ
J Clin Oncol; 2002 Mar; 20(6):1434-5. PubMed ID: 11896086
[No Abstract] [Full Text] [Related]
11. A rare case of non-immune hemolytic anemia in a patient with metastatic breast cancer treated with capecitabine.
Shaaban H; Downs E; Shakouri P; Guron G
Med Oncol; 2013 Mar; 30(1):321. PubMed ID: 23254961
[No Abstract] [Full Text] [Related]
12. Capecitabine-related cardiotoxicity: recognition and management.
Saif MW; Tomita M; Ledbetter L; Diasio RB
J Support Oncol; 2008 Jan; 6(1):41-8. PubMed ID: 18257400
[No Abstract] [Full Text] [Related]
13. Capecitabine-associated coronary vasospasm: a case report.
Papadopoulos CA; Wilson H
Emerg Med J; 2008 May; 25(5):307-9. PubMed ID: 18434478
[TBL] [Abstract][Full Text] [Related]
14. Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function.
Schüll B; Scheithauer W; Kornek GV
Onkologie; 2003 Dec; 26(6):578-80. PubMed ID: 14709934
[TBL] [Abstract][Full Text] [Related]
15. Lethal toxicity of capecitabine due to abusive folic acid prescription?
Clippe C; Freyer G; Milano G; Trillet-Lenoir V
Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):299-300. PubMed ID: 12924465
[No Abstract] [Full Text] [Related]
16. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
Bar-Sela G; Haim N
Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine: an overview of the side effects and their management.
Saif MW; Katirtzoglou NA; Syrigos KN
Anticancer Drugs; 2008 Jun; 19(5):447-64. PubMed ID: 18418212
[TBL] [Abstract][Full Text] [Related]
18. Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
Serrão VV; Feio AB
Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393
[No Abstract] [Full Text] [Related]
19. Capecitabine as an alternative in a case of fluorouracil-induced photodermatitis.
Tsoussis S; Vourliotaki I; Ekonomidou F; Apostolakis S
Clin Oncol (R Coll Radiol); 2006 Mar; 18(2):158-9. PubMed ID: 16523824
[No Abstract] [Full Text] [Related]
20. Capecitabine induced cardiotoxicity: a case report and review of literature.
Tunio MA; Hashmi A; Shoaib M
Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
